GlassScriptPhysician profile
Brooke L Slaton
NPI 1861421794
$2,184.27
in general payments reported to CMS, 2019-2025
27 companies · $476 in 2025
The $476 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $97.01 · 2021: $334 · 2022: $140 · 2023: $287 · 2024: $358 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.97 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $391.01 | 2019-2025 | |
| Astellas Pharma US INC | $364.51 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $323.45 | 2019-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Abbvie INC. | $208.53 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Avion Pharmaceuticals | $81.90 | 2020-2021 | |
| Agile Therapeutics, INC. | $57.70 | 2021 | |
| Daiichi Sankyo INC. | $55.55 | 2019 | |
| Roche Diagnostics Corporation | $54.26 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $52.04 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $51.20 | 2024 | |
| Dexcom, INC. | $48.47 | 2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $45.71 | 2019 | |
| Coopersurgical, INC. | $45.61 | 2019-2023 | Paragard T 380a |
| Minerva Surgical, INC | $44.72 | 2019 | |
| Organon LLC | $43.02 | 2022-2025 | Nexplanon |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $42.02 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $41.36 | 2021-2022 | |
| Evofem Biosciences, INC. | $37.30 | 2021 | |
| Therapeuticsmd, INC. | $32.41 | 2019-2021 | |
| Pfizer INC. | $31.84 | 2023 | |
| Lupin INC. | $25.41 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $24.08 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mylan Pharmaceuticals INC. | $22.41 | 2019 | |
| Ethicon US, LLC | $18.72 | 2024 | Surgicel Nu-Knit |
| Organogenesis INC. | $16.48 | 2025 | Nushield |
| Merck Sharp & Dohme LLC | $12.31 | 2019 | |
| Channel Medsystems, INC. | $12.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Slaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.